2.1.1.2 Policy
- Receipt of benefits from any source of sponsored research must be acknowledged and conflicts of interest must be disclosed in the Cochrane Database of Systematic Reviews and other publications that emanate from The Cochrane Collaboration.
- If an author is involved in a trial included in his/her review, this must be acknowledged, as it could be perceived as a potential conflict of interest.
- If a proposal raises a question of serious conflict of interest, this should be forwarded to the local Cochrane Centre for review (and the Steering Group notified accordingly). If the issue involves a Cochrane Centre, the issue should be referred to the Steering Group.
- It is not mandatory to send funding proposals to the local Cochrane Centre or Steering Group before accepting them. However, such reviews would be desirable in cases of restricted donations, or any donation that appears to conflict with the general principle. Any funding that may be in conflict with The Cochrane Collaboration’s policy on commercial sponsorship (see section 2.3) should be reviewed by the Funding Arbiter (see section 1.1.2.4).
- The Steering Group (via the Monitoring and Registration Committee) should receive (and review at least annually) information about all external funds accepted by Cochrane entities. All such funds should comply with The Cochrane Collaboration’s policy on commercial sponsorship (see section 2.3).
Download The Cochrane Policy Manual in PDF format.
Attention: Please note that this PDF version is generated nightly and thus may not reflect changes made in the last 24 hours.
Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org
